Catalyst Pharmaceuticals
NasdaqCM:CPRX Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 65 Fair Values set on narratives written by author
WA
Consensus Narrative from 9 Analysts
Global Expansion Of FIRDAPSE And AGAMREE Will Broaden Future Market Access
Key Takeaways Strong performance and international expansion of FIRDAPSE, especially into Japan, are positioned to increase global revenue streams for Catalyst. Strategic partnerships and global market expansion, including new product launches, promise to enhance revenue and broaden Catalyst's portfolio.
View narrativeUS$32.75
FV
30.0% undervalued intrinsic discount13.89%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
21 days ago author updated this narrative